It’s perfectly normal for our skin to get wrinkles and fine lines as we age—but if you’re looking to achieve a smoother-looking complexion, the best wrinkle fillers can help. Often marketed as ...

To launch its new product, Laura Geller Beauty is partnering with “Real Housewives of New Jersey” star and “The Traitors” season three winner Dolores Catania. The new Line Smoother Targeted Fine Line ...

NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Laura Geller Beauty, the brand known for makeup made for mature skin, is proud to announce the launch of its new Line Smoother Targeted Fine Line Filler -- an ...

The brand's latest innovation smooths fine lines and boosts confidence – launching with a playful "Beauty Emergency Unit" campaign. To bring the launch to life, the brand is rolling out a ...

This article is a part of CNN Underscored’s Guide to Age-Defying Beauty, a weeklong focus on the essential products, tips and tricks to enhance your glow at any age. We’ll be featuring editor-tested ...

Pfizer Inc. announced detailed results from the phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor Tukysa (tucatinib) as part of an investigational first-line maintenance treatment ...

Full disclosure: as a beauty editor, I’m not ashamed to admit that in a bid to look younger than my 45 years, I’ve tried a fair few tweakments. I first dabbled in dermal filler when I turned 41 after ...

Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule ...

Findings showed datopotamab deruxtecan significantly improved PFS and OS vs chemotherapy. Topline data were announced from a phase 3 trial evaluating datopotamab deruxtecan-dlnk as a first-line ...

Good afternoon, and thank you for joining us for this special conference call to discuss ROVI's acquisition of an injectable drug product manufacturing site in Phoenix, Arizona, which we announced ...

CHEONGJU, South Korea--(BUSINESS WIRE)--Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a ...

Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD Expand the global customer network by leveraging the BD&CMO Partnership Program Triple production capacity ...